SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
SeaStar Medical's post-approval SAVE Registry data on QUELIMMUNE (SCD-PED) was accepted as a late-breaking poster at ASN Kidney Week 2026 in Denver on October 22. The abstract, titled 'Improved Outcomes in Pediatric Sepsis-Associated AKI,' compares the pediatric SAVE Registry with a historical cohort, suggesting favorable real-world outcome data ahead of formal presentation.
Key figures
- Drug Name
- QUELIMMUNE (SCD-PED)
- Presentation id
- TH-PO1291
- Presentation date
- October 22, 2026, 10:00 a.m.-12:00 p.m. MT
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.